Non-proprietary names from 'tsimitsifugi' to 'tsitrullina' - Electronic medicinal guide TALKDRUGS

V.F40-F48.F45.3   Somatoform dysfunction of the autonomic nervous system

V.F50-F59.F51.2   Sleep and wakefulness disorder inorganic etiology

VI.G40-G47.G43   Migraine

IX.I10-I15.I10   Essential [primary] hypertension

IX.I70-I79.I70   Atherosclerosis

XIV.N80-N98.N95.1   Menopause and menopause in women

XV.O10-O16.O13   Pregnancy-induced hypertension without significant proteinuria

IV.E20-E35.E21.2   Other forms of hyperparathyroidism

IV.E20-E35.E21.1   Secondary hyperparathyroidism, not elsewhere classified

IV.E20-E35.E21.0   Primary hyperparathyroidism

II.C73-C75.C75.0   Malignant neoplasm of parathyroid [parathyroid] gland

XIV.N17-N19.N18.0   Terminal stage of kidney damage

XIV.N25-N29.N25.8   Other disorders due to renal tubular dysfunction

XII.L60-L75.L70   Acne

XIX.T51-T65.T58   Toxic effect of carbon monoxide

XX.X40-X49.X47   Accidental poisoning and exposure to other gases and vapors

XIX.T51-T65.T59   Toxic effect of other gases, fumes and vapors

XII.L80-L99.L97   Ulcer of lower limb, not elsewhere classified

XII.L80-L99.L89   Decubital ulcer

XII.L60-L75.L70   Acne

XIX.T08-T14.T14.1   Open wound of unspecified area of ​​the body

XII.L00-L08.L08.9   Local infection of skin and subcutaneous tissue, unspecified

XIX.T79.T79.3   Post-traumatic wound infection, not elsewhere classified

XII.L55-L59.L56.2   Photocontact dermatitis [berloque dermatitis]

XII.L20-L30.L30.9   Dermatitis, unspecified

XII.L20-L30.L25   Contact dermatitis, unspecified

I.B00-B09.B00.9   Herpetic infection, unspecified

XII.L00-L08.L08.0   Pyoderma

XII.L20-L30.L30.4   Erythematous intermittence

XII.L80-L99.L89   Decubital ulcer

XIX.T08-T14.T14.0   Superficial injury of unspecified area of ​​the body

XIX.T08-T14.T14.1   Open wound of unspecified area of ​​the body

XIX.T20-T32.T30   Thermal and chemical burns, unspecified

XII.L20-L30.L30.3   Infectious dermatitis

XII.L20-L30.L20.8   Other atopic dermatitis

IV.E10-E14.E14   Diabetes mellitus, unspecified

IV.E50-E64.E60   Alimentary insufficiency of zinc

VI.G80-G83.G80   Cerebral palsy

VII.H10-H13.H10.9   Conjunctivitis, unspecified

XII.L60-L75.L63   Alopecia areata

XII.L60-L75.L70   Acne

XIV.N70-N77.N76   Other inflammatory diseases of the vagina and vulva

XIX.T08-T14.T14.1   Open wound of unspecified area of ​​the body

XVIII.R40-R46.R45.4   Irritability and anger

XVIII.R40-R46.R42   Dizziness and dizziness

XVIII.R20-R23.R20.2   Paresthesia of the skin

IX.I70-I79.I73.9   Peripheral vascular disease, unspecified

XIX.T66-T78.T75.3   Motion Slicking

IX.I80-I89.I83.0   Varicose veins of the lower extremities with ulcer

IX.I70-I79.I79.2 *   Peripheral angiopathy in diseases classified elsewhere

IX.I70-I79.I73.1   Obliterating thromboangitis [Berger's disease]

IX.I70-I79.I73.0   Raynaud's syndrome

IX.I60-I69.I69.3   Consequences of a cerebral infarction

IX.I60-I69.I67.9   Cerebrovascular disease, unspecified

IX.I60-I69.I67.2   Cerebral atherosclerosis

VIII.H80-H83.H81.9   Violation of vestibular function, unspecified

VII.H55-H59.H55   Nystagmus and other involuntary eye movements

VI.G90-G99.G93.4   Encephalopathy, unspecified

VI.G40-G47.G43   Migraine

V.F90-F98.F90.0   Violation of activity and attention

V.F00-F09.F07.2   Postcontasia syndrome

V.F00-F09.F03   Dementia, unspecified

XII.L20-L30.L30.9   Dermatitis, unspecified

XII.L20-L30.L23   Allergic contact dermatitis

XII.L20-L30.L20   Atopic dermatitis

XVIII.R50-R69.R63.0   Anorexia

XII.L20-L30.L29   Itching

X.J30-J39.J30   Vasomotor and allergic rhinitis

XI.K80-K87.K86.1   Other chronic pancreatitis

VII.H10-H13.H10.1   Acute atopic conjunctivitis

VI.G40-G47.G43   Migraine

XVIII.R50-R69.R51   Headache

XVIII.R20-R23.R21   Rash and other nonspecific skin rashes

XX.W50-W64.W57   Bite or sting with a non-toxic insect or other non-venous arthropod

XIX.T80-T88.T80.6   Other serum reactions

II.C60-C63.C61   Malignant neoplasm of prostate

XII.L60-L75.L64   Androgenic alopecia

IV.E20-E35.E28.1   Excess androgens

IV.E20-E35.E30.1   Premature puberty

V.F50-F59.F52.7   Increased libido

XII.L20-L30.L21.8   Other seborrheic dermatitis

XII.L60-L75.L68.0   Hirsutism

XII.L60-L75.L70.8   Other acne

XIII.M80-M85.M81.1   Osteoporosis after removal of ovaries

XIII.M80-M85.M81.0   Postmenopausal osteoporosis

XIV.N80-N98.N91   Absence of menstruation, meager and rare menstruation

XIV.N80-N98.N95.1   Menopause and menopause in women

XIV.N80-N98.N95.3   Conditions associated with artificially induced menopause

XII.L20-L30.L21   Seborrheic dermatitis

XII.L60-L75.L64   Androgenic alopecia

XII.L60-L75.L68.0   Hirsutism

XII.L60-L75.L70   Acne

XXI.Z30-Z39.Z30.0   General advice and advice on contraception

IV.E70-E90.E78.1   Pure hyperglyceridemia

IV.E70-E90.E78.0   Pure hypercholesterolemia

IV.E70-E90.E78.2   Mixed hyperlipidemia

XIV.N10-N16.N10   Acute tubulointerstitial nephritis

XI.K80-K87.K81.0   Acute cholecystitis

XI.K65-K67.K65.0   Acute peritonitis

X.J20-J22.J20   Acute bronchitis

X.J00-J06.J04   Acute laryngitis and tracheitis

X.J00-J06.J03   Acute tonsillitis

X.J00-J06.J02   Acute pharyngitis

X.J00-J06.J01   Acute Sinusitis

X.J00-J06.J00   Acute nasopharyngitis (runny nose)

VII.H00-H06.H04.3   Acute and unspecified inflammation of lacrimal ducts

XIV.N10-N16.N11   Chronic tubulointerstitial nephritis

XI.K80-K87.K81.1   Chronic cholecystitis

X.J40-J47.J42   Chronic bronchitis, unspecified

X.J30-J39.J37   Chronic laryngitis and laryngotracheitis

X.J30-J39.J35.0   Chronic tonsillitis

X.J30-J39.J32   Chronic Sinusitis

X.J30-J39.J31.2   Chronic pharyngitis

X.J30-J39.J31.0   Chronic rhinitis

X.J30-J39.J31   Chronic rhinitis, nasopharyngitis and pharyngitis

VII.H10-H13.H10.4   Chronic conjunctivitis

VII.H00-H06.H04.4   Chronic inflammation of lacrimal ducts

I.A30-A49.A41   Other septicemia

I.A30-A49.A40   Streptococcal septicemia

VII.H00-H06.H01.0   Blepharitis

VII.H10-H13.H10.2   Other acute conjunctivitis

VIII.H65-H75.H66   Purulent and unspecified otitis media

XI.K80-K87.K83.0   Cholangitis

XII.L00-L08.L03   Phlegmon

XIII.M86-M90.M86   Osteomyelitis

XIV.N30-N39.N30   Cystitis

XIV.N30-N39.N34   Urethritis and urethral syndrome

XXI.Z40-Z54.Z51.4   Preparatory procedures for subsequent treatment, not elsewhere classified

II.C73-C75.C74   Malignant neoplasm of adrenal gland

II.C64-C68.C67   Malignant neoplasm of bladder

II.C60-C63.C62   Malignant neoplasm of testis

II.C60-C63.C61   Malignant neoplasm of prostate

II.C60-C63.C61   Malignant neoplasm of prostate

II.C60-C63.C60   Malignant neoplasm of penis

II.C51-C58.C58   Malignant neoplasm of placenta

II.C51-C58.C58   Malignant neoplasm of placenta

II.C51-C58.C57   Malignant neoplasm of other and unspecified female genital organs

II.C51-C58.C54   Malignant neoplasm of uterine body

II.C51-C58.C53   Malignant neoplasm of cervix

II.C50   Malignant neoplasm of breast)

II.C45-C49.C49   Malignant neoplasm of other types of connective and soft tissue

II.C45-C49   Malignant neoplasms of mesothelial and soft tissues

II.C43-C44.C44   Other malignant neoplasms of the skin

II.C43-C44   Melanoma and other malignant neoplasms of the skin

II.C40-C41.C41   Malignant neoplasm of bones and articular cartilages of other and unspecified sites

II.C30-C39.C39   Malignant neoplasm of other and inaccurately marked localizations of the respiratory and intrathoracic organs

II.C30-C39.C34   Malignant neoplasm of bronchi and lungs

II.C30-C39.C32   Malignant neoplasm of larynx

II.C30-C39.C31   Malignant neoplasm of paranasal sinuses

II.C30-C39.C30   Malignant neoplasm of nasal cavity and middle ear

II.C15-C26.C26   Malignant neoplasm of other and inaccurately indicated digestive organs

II.C15-C26.C20   Malignant neoplasm of rectum

II.C15-C26.C20   Malignant neoplasm of rectum

II.C15-C26.C17   Malignant neoplasm of small intestine

II.C15-C26.C16   Malignant neoplasm of stomach

II.C15-C26   Malignant neoplasms of the digestive system

II.C00-C14.C11   Malignant neoplasm of nasopharynx

II.C00-C14.C10   Malignant neoplasm of oropharynx

II.C00-C14.C09   Malignant neoplasm of tonsil

II.C81-C96.C84   Peripheral and cutaneous T-cell lymphomas

II.C81-C96.C83   Diffuse non-Hodgkin's lymphoma

II.C81-C96.C82.9   Follicular non-Hodgkin's lymphoma, unspecified

XV.O00-O08.O01.9   Biliary drift, unspecified

II.C81-C96.C90   Multiple myeloma and malignant plasma cell neoplasms

XX.Y83-Y84.Y84.2   Radiological procedure and radiation therapy

XIX.T66-T78.T66   Unspecified radiation effects

X.J40-J47.J45   Asthma

VI.G30-G32.G30   Alzheimer's disease

X.J40-J47.J42   Chronic bronchitis, unspecified

X.J40-J47.J40   Bronchitis, not specified as acute or chronic

XIV.N30-N39.N30.9   Cystitis, unspecified

X.J10-J18.J18.9   Pneumonia, unspecified

IV.E40-E46.E46   Protein-energy insufficiency, unspecified

V.F40-F48.F42   Obsessive-compulsive disorder

V.F40-F48.F41.2   Mixed anxiety and depressive disorder

V.F40-F48.F41.0   Panic disorder [episodic paroxysmal anxiety]

V.F40-F48.F41   Other anxiety disorders

V.F30-F39.F33   Recurrent depressive disorder

V.F30-F39.F31   Bipolar affective disorder

V.F30-F39.F32   Depressive episode

II.C81-C96.C92.9   Myeloid leukemia, unspecified

II.C81-C96.C92.1   Chronic myeloid leukemia

II.C81-C96.C92.0   Acute myeloid leukemia

II.C81-C96.C91.9   Lymphoid leukemia, unspecified

II.C81-C96.C91.0   Acute lymphoblastic leukemia

II.C81-C96.C81   Hodgkin's disease [lymphogranulomatosis]

II.D37-D48.D46   Myelodysplastic syndromes

II.C81-C96.C85.9   Non-Hodgkin's lymphoma, unspecified

V.F10-F19.F17   Mental and behavioral disorders caused by tobacco use

XXI.Z70-Z76.Z72.0   Tobacco use

XIX.T51-T65.T65.2   Toxic effect of tobacco and nicotine

XIX.T90-T98.T90.5   Consequences of intracranial injury

IX.I60-I69.I69.3   Consequences of a cerebral infarction

IX.I60-I69.I69.1   Consequences of intracranial hemorrhage

V.F00-F09.F06.7   Mild cognitive impairment

V.F00-F09.F07   Personality and behavioral disorders due to illness, damage or dysfunction of the brain

V.F90-F98.F91   Behavioral disorders

IX.I60-I69.I61   Intracerebral haemorrhage

IX.I60-I69.I63   Cerebral infarction

IX.I60-I69.I67.9   Cerebrovascular disease, unspecified

XIX.S00-S09.S06   Intracranial injury

I.B15-B19.B19   Viral hepatitis, unspecified

VII.H15-H22.H16   Keratite

VII.H15-H22.H18.4   Degeneration of the cornea

VII.H15-H22.H17   Scars and opacity of the cornea

IX.I30-I52.I50.9   Heart failure, unspecified

IX.I60-I69.I67.9   Cerebrovascular disease, unspecified

X.J10-J18.J18   Pneumonia without clarification of the pathogen

X.J95-J99.J96   Respiratory failure, not elsewhere classified

XI.K70-K77.K72   Hepatic failure, not elsewhere classified

XVI.P20-P29.P21   Asphyxia in childbirth

XIX.T36-T50.T42   Poisoning with anticonvulsant, sedative, hypnotics, and anti-Parkinsonics

XIX.T51-T65.T59   Toxic effect of other gases, fumes and vapors

XIX.T51-T65.T58   Toxic effect of carbon monoxide

XVIII.R50-R69.R53   Malaise and fatigue

XXI.Z70-Z76.Z73.3   Stress condition, not elsewhere classified

XXI.Z70-Z76.Z73.0   Overwork

V.F40-F48.F48.0   Neurasthenia

IV.E50-E64.E63.1   Unbalanced intake of food items

XXI.Z40-Z54.Z54   Condition of recovery